GNMK Share Price

Open 9.45 Change Price %
High 9.56 1 Day -0.06 -0.62
Low 9.33 1 Week -0.45 -4.50
Close 9.54 1 Month -2.51 -20.83
Volume 275461 1 Year 0.87 10.03
52 Week High 13.67
52 Week Low 8.03
GNMK Important Levels
Resistance 2 9.75
Resistance 1 9.67
Pivot 9.48
Support 1 9.41
Support 2 9.33
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DCTH 0.13 -13.33%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
More..
NASDAQ USA Top Gainers Stocks
ARCI 1.45 137.70%
FALC 0.40 60.00%
AMCF 0.03 50.00%
LOCM 0.09 50.00%
OPXAW 0.10 42.86%
VRTA 4.50 38.46%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
ATRM 1.70 21.43%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
PTSX 0.05 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

GenMark Diagnostics, Inc. (NASDAQ: GNMK)

GNMK Technical Analysis 5
As on 21st Aug 2017 GNMK Share Price closed @ 9.54 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 12.03 & Strong Sell for SHORT-TERM with Stoploss of 11.59 we also expect STOCK to react on Following IMPORTANT LEVELS.
GNMK Target for August
1st Target up-side 12.66
2nd Target up-side 13.25
3rd Target up-side 13.83
1st Target down-side 11
2nd Target down-side 10.41
3rd Target down-side 9.83
GNMK Other Details
Segment EQ
Market Capital 273291424.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.genmarkdx.com
GNMK Address
GNMK
5964 La Place Court
Carlsbad, CA 92008
United States
Phone: 760-448-4300
Fax: 760-448-4301
GNMK Latest News
Interactive Technical Analysis Chart GenMark Diagnostics, Inc. ( GNMK NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on GenMark Diagnostics, Inc.
GNMK Business Profile
GenMark Diagnostics, Inc. (GenMark) is a molecular diagnostics company focused on developing and commercializing its eSensor detection technology. The Company�s electrochemical technology enables detection of up to 72 distinct biomarkers in a single sample. Its XT-8 System has received 510(k) clearance from the United States Food and Drug Administration (FDA), and is designed to support a range of molecular diagnostic tests with a compact workstation and self-contained, disposable test cartridges. Within 30 minutes of receipt of an amplified deoxyribonucleic acid (DNA) sample, its XT-8 System produces results. The XT-8 System supports up to 24 test cartridges, which can be run independently, and are targeted for hospitals and reference laboratories. The Company is also developing its next-generation platform, the AD-8 System, to integrate DNA amplification with its eSensor detection technology to enable technicians to place a minimally prepared patient sample into its test cartridge.